PharmEasy parent API Holdings gets SEBI's approval for Rs 6250 crore IPO
PharmEasy parent API Holdings has received market regulator SEBI approval for its Rs 6,250 crore initial public offering (IPO).
Source: techstory.in
Stay updated with breaking news from Api Holdings. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
PharmEasy parent API Holdings has received market regulator SEBI approval for its Rs 6,250 crore initial public offering (IPO).
50,000 Covishield doses will be given in Pune Municipal Corporation region
Going by the draft papers, API Holdings is looking to raise Rs 6,250 crore through the IPO.
The API Holdings IPO will entirely be a fresh issue with only a primary share sale of an unspecified number of shares worth ₹6,250 crore.
PharmEasy's parent company, API Holdings, has received clearance from SEBI to raise funds through an Initial Public Offering.